LEXINGTON, Mass., May 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that the Company will report its first quarter 2026...
Hence then, the article about curis to report first quarter 2026 financial and operating results and host conference call and webcast on may 12 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 )
Also on site :
- ‘Big Brother’ Season 28, Week 7 Eviction: A Celebration Of 1,000 Episodes & Another Houseguest Is Voted Out
- Trump – named America’s worst ever president by panel of experts – puts out his own chart listing himself as the greatest
- Stuart Fails To Save The Universe Cast Talks Cow Stomachs, Free-Fall Stunts — Plus, Big Bang Theory Star Returns In Episode 6